Tysabri is a type of disease modifying drug used in the treatment of certain forms of multiple sclerosis (MS). This medication works by preventing leukocytes from crossing the blood-brain barrier into the nervous system where they may exacerbate MS lesions. Tysabri is provided in concentrate form (300mg in 15 ml) for infusion.